Skip to main content
Log in

Extraction of defibrillator leads recalled for cable externalization and failure

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Background

The Riata implantable cardioverter–defibrillator lead was recalled by the Food and Drug Administration because of an increased rate of failure associated with cable externalization. Because of its mechanical separation, the Riata lead may be challenging to extract. We therefore examined the experience with Riata lead extractions at our institution.

Methods

All patients implanted with the Riata lead underwent detailed review of their electronic medical records and operative notes. Procedural complications were ascertained by reviewing the medical records up to 30 days after Riata extraction.

Results

From a total of 627 patients implanted with the Riata lead at our institution, 20 patients (age at time of extraction, 57 ± 11 years; 85 % men; lead dwell time, 48 ± 27 months) underwent lead extraction. Extraction was successful in 19 of 20 (95 %) patients and required the use of laser-powered sheaths in 18 (90 %) patients. Over a 30-day follow-up period, 1 of 20 (5 %) patients had a minor procedure-related complication consisting of a new pericardial effusion that did not require drainage.

Conclusions

Extraction of the Riata lead seems to be successful and safe and frequently requires the use of powered sheaths.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Cannom, D. S., & Prystowky, E. N. (2004). Evolution of the implantable cardioverter defibrillator. Journal of Cardiovascular Electrophysiology, 15, 375–385.

    Article  PubMed  Google Scholar 

  2. St. Jude Medical. (2002). St. Jude Medical announces FDA approval of the world's thinnest, most advanced defibrillation lead family [News Release]. Retrieved from http://investors.sjm.com/phoenix.zhtml?c=73836&p=irol-newsArticle&ID=278673&highlight=.

  3. Israel, C. W., Duray, G. Z., Schmitt, J., & Hohnloser, S. H. (2008). Implantable cardioverter–defibrillator lead disintegration at the level of the tricuspid valve. Heart Rhythm, 5, 1224–1225.

    Article  PubMed  Google Scholar 

  4. Jalal, Z., Derval, N., Ploux, S., & Bordachar, P. (2010). Unusual failure of a multilumen, small-diameter implantable cardioverter–defibrillator lead. Heart Rhythm, 7, 1166–1167.

    Article  PubMed  Google Scholar 

  5. Hauser, R. G., Abdelhadi, R., McGriff, D., & Retel, L. K. (2012). Deaths caused by the failure of Riata and Riata ST implantable cardioverter–defibrillator leads. Heart Rhythm, 9, 1227–1235.

    Article  PubMed  Google Scholar 

  6. Parvathaneni, S. V., Ellis, C. R., & Rottmann, J. N. (2012). High prevalence of insulation failure with externalized cables in St. Jude Medical Riata family ICD leads: Fluoroscopic grading scale and correlation to extracted leads. Heart Rhythm, 9, 1218–1224.

    Google Scholar 

  7. US Food and Drug Administration (FDA). (2011). FDA classifies voluntary physician advisory letter on Riata and Riata ST silicone defibrillation leads as class I recall [Press Release]. Retrieved from http://www.fda.gov/Safety/Recalls/ucm283879.htm.

  8. Wilkoff, B. L., Love, C. J., Byrd, C. L., Bongiorni, M. G., Carrillo, R. G., Crossley, G. H., 3rd, et al. (2009). Transvenous lead extraction: Heart Rhythm Society’s expert consensus on facilities, training, indications, and patient management. Heart Rhythm, 6, 1085–1104.

    Article  PubMed  Google Scholar 

  9. Kennergren, C., Bjurman, C., Wiklund, R., & Gabel, J. (2009). A single-centre experience of over one thousand lead extractions. Europace, 11, 612–617.

    Article  PubMed  Google Scholar 

  10. Jones, S. O., Eckart, R. E., Albert, C. M., & Epstein, L. M. (2008). Large, single-center, single-operator experience with transvenous lead extraction: Outcomes and changing indications. Heart Rhythm, 5, 520–525.

    Article  PubMed  Google Scholar 

  11. Maytin, M., Love, C. J., Fischer, A., Carrillo, R. G., Garisto, J. D., Bongiorni, M. G., et al. (2010). Multicenter experience with extraction of the Sprint Fidelis implantable cardioverter–defibrillator lead. Journal of the American College of Cardiology, 56, 646–650.

    Article  PubMed  Google Scholar 

  12. Hauser, R. G., Kallinen, L. M., Almquist, A. K., Gornick, C. C., & Katsiyiannis, W. T. (2007). Early failure of a small-diameter high-voltage implantable cardioverter–defibrillator lead. Heart Rhythm, 4, 892–896.

    Article  PubMed  Google Scholar 

  13. Krahn, A. D., Champagne, J., Healey, J. S., Cameron, D., Simpson, C. S., Thibault, B., et al. (2008). Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: A report from the Canadian Heart Rhythm Society Device Advisory Committee. Heart Rhythm, 5, 639–642.

    Article  PubMed  Google Scholar 

  14. Gaca, J. G., Lima, B., Milano, A., Lin, S. S., Davis, R. D., Lowe, J. E., et al. (2009). Laser-assisted extraction of pacemaker and defibrillator leads: The role of the cardiac surgeon. The Annals of Thoracic Surgery, 87, 1446–1450.

    Article  PubMed  Google Scholar 

  15. Epstein, L. M., Byrd, C. L., Wilkoff, B. L., Love, C. J., Sellers, T. D., Hayes, D. L., et al. (1999). Initial experience with larger laser sheaths for the removal of transvenous pacemaker and implantable defibrillator leads. Circulation, 100, 516–525.

    Article  PubMed  CAS  Google Scholar 

  16. Wilkoff, B. L., Byrd, C. L., Love, C. J., Hayes, D. L., Sellers, T. D., Schaerf, R., et al. (1999). Pacemaker lead extraction with the laser sheath: Results of the pacing lead extraction with the excimer sheath (Plexes) trial. Journal of the American College of Cardiology, 33, 1671–1676.

    Article  PubMed  CAS  Google Scholar 

  17. Epstein, A. E., Kay, G. N., Plumb, V. J., Dailey, S. M., & Anderson, P. G. (1998). Gross and microscopic pathological changes associated with nonthoracotomy implantable defibrillator leads. Circulation, 98, 1517–1524.

    Article  PubMed  CAS  Google Scholar 

  18. Kolodzinska, A., Kutarski, A., Koperski, L., Jarzyna, I., Małecka, B., & Opolski, G. (2012). Differences in encapsulating lead tissue in patients who underwent transvenous lead removal. Europace, 14, 994–1001.

    Article  PubMed  Google Scholar 

  19. Martin, D. T., Hook, B. G., Chaudhry, G. M., & Silver, J. (2011). Multicenter experience with extraction of the Sprint Fidelis implantable cardioverter–defibrillator lead. Journal of the American College of Cardiology, 57, 635–636.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

None.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Samir Saba.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Patel, D., Adelstein, E., Nemec, J. et al. Extraction of defibrillator leads recalled for cable externalization and failure. J Interv Card Electrophysiol 36, 273–278 (2013). https://doi.org/10.1007/s10840-012-9751-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-012-9751-9

Keywords

Navigation